Reaction time and movement time after embryonic cell implantation in Parkinson disease

Archives of Neurology

Volumn 61, Issue 6, 2004, Pages 858-861

  Gordon, Paul H ^a   Yu, Qiping ^a   Qualls, Clifford ^b   Winfield, Hal ^a   Dillon, Sandra ^a   Greene, Paul E ^a   Fahn, Stanley ^a   Breeze, Robert E ^c   Freed, Curt R ^c,d   Pullman, Seth L ^a,e  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BODY MOVEMENT; CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETERIORATION; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; EMBRYO CELL; EMBRYONAL TISSUE; EMBRYONIC CELL TRANSPLANTATION; HUMAN; MOTOR PERFORMANCE; PARKINSON DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; BRAIN TISSUE TRANSPLANTATION; DOUBLE-BLIND METHOD; FEMALE; FETAL TISSUE TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SUBSTANTIA NIGRA;

EID: 2942626185     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.6.858     Document Type: Article

References (25)

1. Fahn S, Clarence-Smith KE, Chase TN. Parkinson's disease: neurodegenerative mechanisms and neuroprotective interventions-report of a workshop. Mov Disord. 1998;13:759-767.
2. Speelman JD, Bosch DA. Resurgence of functional neurosurgery for Parkinson's disease: a historical perspective. Mov Disord. 1998;13:582-588.
3. Ward CD, Sanes JN, Dambrosia JM, Calne DB. Methods for evaluating treatment in Parkinson's disease. Adv Neurol. 1983;37:1-7;
4. Pullman SL, Watts RL, Juncos JL, Sanes JN. Movement amplitude choice reaction time performance in Parkinson's disease may be independent of dopaminergic status. J Neurol Neurosurg Psychiatry. 1990;53:279-283.
5. Wilson SAK. Some disorders of motility and of muscle tone, with special reference to the corpus striatum. Lancet. 1925;2:1-276.
6. Montgomery EBJ, Nuessen J, Gorman D. Reaction time and movement velocity abnormalities in Parkinson's disease under different task conditions. Neurology. 1991;41:1476-1481.
7. Heilman KM, Bowers D, Watson RT, Greer M. Reaction times in Parkinson's disease. Arch Neurol. 1976;33:139-140.
8. Gauntlett-Gilbert J, Brown VJ. Reaction time deficits and Parkinson's disease. Neurosci Biobehav Rev. 1998;22:865-881.
9. Jordan N, Sagar HJ, Cooper JA. Cognitive components of reaction time in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1992;55:658-664.
10. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci. 1986;9:357-381.
11. Kutukcu Y, Marks WJ Jr, Goodin DS, Aminoff MJ. Simple and choice reaction time in Parkinson's disease. Brain Res. 1999;815:367-372.
12. Roy EA, Saint-Cyr J, Taylor A, Lang A. Movement sequencing disorders in Parkinson's disease. Int J Neurosci. 1993;73:183-194.
13. Djaldetti R, Ziv I, Melamed E. The effect of deprenyl washout in patients with long-standing Parkinson's disease. J Neural Transm. 2002;109:797-803.
14. Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med. 2001;344:710-719.
15. Pullman SL, Watts RL, Juncos JL, Chase TN, Sanes JN. Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease. Neurology. 1988;38:249-254.
16. Olanow CW, Goetz CG, Kordower JH, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol. 2003;54: 403-414.
17. Evarts EV, Teräväinen HT, Calne DB. Reaction time in Parkinson's'disease. Brain. 1981;104:167-186.
18. Muller T, Eising E, Kuhn W, Buttner T, Coenen HH, Przuntek H. Delayed motor response correlates with striatal degeneration in Parkinson's disease. Acta Neurol Scand. 1999;100:227-230.
19. Hayashi R, Hanyu N, Shindo M, Tamaru F, Yanagisawa N. Event-related potentials, reaction time, and cognitive state in patients with Parkinson's disease. Adv Neurol. 1993;60:429-433.
20. Yokochi F, Nakamura R, Narabayashi H. Reaction time of patients with Parkinson's disease, with reference to asymmetry of neurological signs. J Neurol Neurosurg Psychiatry. 1985;48:702-705.
21. Jahanshahi M, Brown RG, Marsden CD. The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1992;55:1168-1176.
22. Starkstein SE, Esteguy M, Bertheir ML, Garcia H, Leiguarda R. Evoked potentials, reaction time and cognitive performance in on and off phases of Parkinson's disease. J Neurol Neurosurg Psychiatry. 1989;52:338-340.
23. Bloxham CA, Mindel TA, Frith CD. Initiation and execution of predictable and unpredictable movements in Parkinson's disease. Brain. 1984;107(pt 2):371-384.
24. Brown RG, Dowsey PL, Brown P, et al. Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease. Ann Neurol. 1999;45:473-488.
25. Jankovic J, Ben-Arie L, Schwartz K, et al. Movement and reaction times and fine coordination tasks following pallidotomy. Mov Disord. 1999;14:57-62.